首页 > 市场调查报告书 > 医疗设备

生技设备

细胞增殖市场规模、份额和成长分析（按产品类型、细胞类型、最终用途和地区划分）—产业预测（2026-2033 年）

市场调查报告书

商品编码

1904174

细胞增殖市场规模、份额和成长分析（按产品类型、细胞类型、最终用途和地区划分）—产业预测（2026-2033 年）

Cell Expansion Market Size, Share, and Growth Analysis, By Product (Consumables and Instruments), By Cell Type (Mammalian Cell, Human Stem Cells), By End Use, By Region -Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，细胞增殖市场规模将达到 335.3 亿美元，到 2025 年将达到 369.8 亿美元，到 2033 年将达到 810.2 亿美元，预测期（2026-2033 年）的复合年增长率为 10.3%。

细胞扩增市场的主要驱动力在于能够提高细胞、基因和生物疗法开发效率的解决方案的进步，这些方案在降低人力成本的同时，也能提供可靠的结果。主要市场参与企业正在扩展其产品线，以满足全球对这些治疗方法日益增长的需求。一次性使用系统 (SUS) 的应用正在革新细胞疗法的生产方式，它最大限度地降低了交叉污染风险，提高了细胞密度，同时降低了长期成本。来自私部门和政府部门的投资增加，以及推广细胞疗法的倡议，都在推动市场成长。此外，为确保产品品质而转向无血清培养基的趋势正在加速发展，这进一步巩固了细胞疗法在生命科学领域的重要性，并推动了市场扩张。

细胞增殖市场驱动因素

细胞增殖技术在生物製药研发中的应用日益广泛，是推动市场成长的关键因素。包括单株抗体、疫苗和细胞疗法在内的生物製药产品，都依赖复杂且可扩展的细胞增殖过程。随着慢性病发病率的上升和全球对个人化医疗需求的日益增长，对高品质生物製药的需求也随之增加。对创新治疗方法的日益关注，推动了对先进细胞增殖技术的投资，进而促进了技术进步和生产效率的提升。这一趋势不仅有助于开发有效的治疗方法，也促进了整个细胞增殖市场的扩张。

限制细胞增殖市场的因素

影响细胞扩增市场的关键限制因素之一是与细胞治疗技术相关的各种监管和伦理挑战。细胞产品的开发和商业化过程需要遵守严格的监管标准，而这些标准在不同地区可能有显着差异。此外，围绕胚胎干细胞的使用和基因编辑技术的应用所引发的伦理困境也带来了进一步的挑战，并可能阻碍研发工作。这些因素共同构成了一个复杂的局面，有可能减缓该领域的进展和创新，因此，相关人员必须有效应对这些障碍。

细胞增殖市场趋势

受对更精确、更符合生理实际的细胞环境的需求驱动，细胞培养市场正经历着向创新3D细胞培养和反应器技术的重大转变。这种从传统2D培养系统的转变显着提高了细胞功能、活力和可重复性，使其成为再生医学、肿瘤学和药物研发领域的关键工具。随着研究人员和临床医生逐渐认识到传统方法的局限性，对先进培养技术的投资正在激增，以支持建立更具预测性的人体生理模型。这一趋势反映了对能够简化药物研发流程并改善治疗效果的高度精密系统日益增长的需求。

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较
主要企业简介
- 赛默飞世尔科技（美国）
- 贝克顿·迪金森公司（美国）
- 龙沙集团（瑞士）
- 康宁公司（美国）
- 默克集团（德国）
- Sartorius Stedim BIoTech SA（德国）
- 泰尔茂株式会社（日本）
- Miltenyi BIoTec GmbH（德国）
- 丹纳赫公司（美国）
- 干细胞技术公司（加拿大）
- 贝克曼库尔特公司（美国）
- Takara Bio Inc.（日本）
- RepliCel 生命科学（加拿大）
- NexImmune公司（美国）
- Celltainer BIoTech BV（荷兰）
- Repligen公司（美国）
- Getinge AB（瑞典）
- Bio-Techne公司（美国）
- PromoCell GmbH（德国）
- Himedia Laboratories（印度）

结论与建议

简介目录

Product Code: SQMIG35J2071

Cell Expansion Market size was valued at USD 33.53 Billion in 2024 and is poised to grow from USD 36.98 Billion in 2025 to USD 81.02 Billion by 2033, growing at a CAGR of 10.3% during the forecast period (2026-2033).

The market for cell expansion is significantly driven by advancements in solutions that enhance efficiency in cell therapy, gene therapy, and biological therapy development, reducing manpower and costs while delivering reliable results. Key market players are broadening their product offerings to address the surging global demand for these therapies. The adoption of single-use systems (SUS) is revolutionizing cell therapy production by minimizing cross-contamination risks and enhancing cell density while lowering long-term costs. Increased investments from both private and government sectors, along with initiatives promoting cellular therapies, are propelling market growth. Additionally, the push for serum-free media to ensure product quality is gaining traction, further solidifying the prominence of cellular therapies in the life sciences arena and driving market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cell Expansion market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cell Expansion Market Segments Analysis

Global Cell Expansion Market is segmented by Product, Cell Type, Application, End Use and region. Based on Product, the market is segmented into Consumables, Culture Flasks and Accessories and Instruments. Based on Cell Type, the market is segmented into Mammalian, Microbial and Others. Based on Application, the market is segmented intobiopharmaceuticals, Tissue Culture & Engineering, Vaccine Production, Drug Development, Gene Therapy, Cancer Research, Stem Cell Research and Others. Based on End Use, the market is segmented into Biopharmaceutical & Biotechnology Companies, Research Institutes, Cell Banks and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Cell Expansion Market

The growing application of cell expansion techniques in biopharmaceutical development serves as a significant catalyst for market growth. Biopharmaceuticals, including monoclonal antibodies, vaccines, and cell-based therapies, depend on intricate and scalable cell expansion processes. As chronic diseases become more prevalent and the demand for personalized medicine rises globally, there is an increasing necessity for high-quality biopharmaceutical products. This heightened focus on innovative therapies drives investments in advanced cell expansion technologies, fostering advancements and enhancing production efficiency. Consequently, this trend not only supports the development of effective treatments but also contributes to the overall expansion of the cell expansion market.

Restraints in the Cell Expansion Market

One significant constraint impacting the cell expansion market is the array of regulatory and ethical challenges associated with cell-based therapeutic technologies. The process of developing and marketing cell-based products necessitates adherence to stringent regulatory standards, which can differ dramatically between various regions. Additionally, ethical dilemmas surrounding the utilization of embryonic stem cells and the application of gene editing techniques pose further difficulties, potentially stifling research and development efforts. These factors combine to create a complex landscape that can slow progress and innovation within the sector, making it essential for stakeholders to navigate these obstacles effectively.

Market Trends of the Cell Expansion Market

The Cell Expansion market is witnessing a significant shift towards innovative 3D cell culture and bioreactor technologies, driven by the need for more accurate and physiologically relevant cellular environments. This transition from traditional 2D culture systems enhances cell function, survival, and reproducibility, making it a vital asset in regenerative medicine, oncology, and drug discovery. As researchers and clinicians recognize the limitations of conventional methods, investments in advanced culture techniques are surging to support more predictive models of human physiology. This trend reflects the broader demand for high-fidelity systems that can streamline the drug development process and improve therapeutic outcomes.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Cell Expansion Market Size by Product & CAGR (2026-2033)

Market Overview
Consumables
- Reagents, Media, & Serum
- Other Consumables
Culture Flasks and Accessories
- Tissue Culture Flasks
- Bioreactor Accessories
- Other Culture Flasks and Accessories
Instruments
- Automated Cell Expansion Systems
- Cell Counters
- Centrifuges
- Bioreactors
- Other Instruments

Global Cell Expansion Market Size by Cell Type & CAGR (2026-2033)

Market Overview
Mammalian
- Human
- Stem Cells (SCs)
- Adult SCs
- Embryonic SCs
- Induced Pluripotent SCs
- Differentiated Cells
- Animal
Microbial
Others

Global Cell Expansion Market Size by Application & CAGR (2026-2033)

Market Overview
Biopharmaceuticals
Tissue Culture & Engineering
Vaccine Production
Drug Development
Gene Therapy
Cancer Research
Stem Cell Research
Others

Global Cell Expansion Market Size by End Use & CAGR (2026-2033)

Market Overview
Biopharmaceutical & Biotechnology Companies
Research Institutes
Cell Banks
Others

Global Cell Expansion Market Size & CAGR (2026-2033)

North America (Product, Cell Type, Application, End Use)
- US
- Canada
Europe (Product, Cell Type, Application, End Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Cell Type, Application, End Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Cell Type, Application, End Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Cell Type, Application, End Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corning Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius Stedim Biotech SA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stemcell Technologies Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beckman Coulter Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RepliCel Life Sciences (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NexImmune Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Celltainer Biotech BV (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Repligen Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Getinge AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PromoCell GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Himedia Laboratories (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments